Showing results (111-120 of 266) with videos related to
Sort By:
Pageof 27
Journal of Hepatology|December 1, 1996
Acute haemodynamic changes after oral carvedilol, a vasodilating beta-blocker, in patients with cirrhosisE H Forrest, I A Bouchier, P C HayesEuropean Journal of Gastroenterology & Hepatology|March 31, 2000
Plasma nitrites/nitrates in HCV infection and hepatocellular carcinomaY I Moussa, J N Plevris, P C HayesAlimentary Pharmacology & Therapeutics|February 18, 2014
Review article: advances in the management of patients with cirrhosis and portal hypertension-related renal dysfunctionJ A Leithead, P C Hayes, J W FergusonBritish Journal of Hospital Medicine|July 9, 1997
Pathophysiology and management of portal hypertension. 2: Cirrhotic ascitesA J Stanley, I A Bouchier, P C HayesScottish Medical Journal|October 1, 1995
Regional survey on the management of oesophageal variceal haemorrhageA J Stanley, J F Dillon, P C HayesGut|March 1, 1988
Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertensionD Westaby, A Gimson, P C Hayes, et al.Alimentary Pharmacology & Therapeutics|February 3, 2009
Review article: hyperammonaemic and catabolic consequences of upper gastrointestinal bleeding in cirrhosisS W M Olde Damink, C H C Dejong, R JalanMetabolic Brain Disease|January 30, 2007
Role of ammonia and inflammation in minimal hepatic encephalopathyD L Shawcross, G Wright, S W M Olde Damink, et al.Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 5, 1999
The prediction of acute cellular rejection in orthotopic liver transplantationA J Bathgate, P Hynd, D Sommerville, et al.Journal of Hepatology|April 6, 1999
Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosisA J Stanley, G Therapondos, A Helmy, et al.Pageof 27